although
molecular
biolog
base
detect
method
alreadi
establish
year
ago
data
occurr
rvi
nicu
still
limit
ronchi
et
al
infant
hospit
nicu
evalu
lateonset
sepsi
incid
rvi
report
ronchi
et
al
ceron
et
al
kidszun
et
al
observ
studi
netherland
found
overal
incid
rvi
nicu
around
verboonmaciolek
et
al
late
concern
increas
nosocomi
respiratori
viru
infect
rate
aros
famili
center
care
liber
visit
polici
nicu
especi
sibl
data
regard
controversi
studi
note
increas
symptomat
rvi
due
sibl
visit
schwab
et
al
solheim
spellaci
moor
et
al
peluso
et
al
horikoshi
et
al
peluso
et
al
hypothes
find
might
differ
openward
nicu
vs
nicu
singlepati
room
peluso
et
al
wherea
other
note
increas
detail
studi
investig
occurr
rvi
nicu
includ
detect
virus
given
tabl
although
report
incid
seem
rel
low
relev
short
longterm
consequ
earlylif
rvi
shall
consid
bennett
et
al
ronchi
et
al
kidszun
et
al
earlylif
rvi
report
associ
increas
length
hospit
stay
sever
diseas
otherwis
avoid
antimicrobi
exposur
nosocomi
outbreak
nicu
gelber
ratner
kidszun
et
al
studi
uk
report
preterm
infant
rvi
need
escal
respiratori
support
episod
respiratori
pressur
support
twice
mani
requir
home
oxygen
furthermor
frequenc
bronchopulmonari
dysplasia
bpd
significantli
higher
among
infant
bennett
et
al
major
patient
hospit
nicu
immatur
inexperienc
innat
adapt
immun
system
van
den
berg
et
al
innat
cytokin
respons
virus
inadequ
convers
overwhelm
thu
associ
increas
diseas
sever
perez
et
al
longterm
impact
earlylif
rvi
lesser
explopor
one
studi
show
associ
lung
function
abnorm
suscept
infant
particularli
recurr
wheez
asthma
followup
school
age
jackson
bennett
et
al
report
complic
longer
length
stay
prolong
ventilatori
support
well
twice
rate
bpd
infant
without
overt
symptom
rvi
posit
viru
detect
birth
hospit
howev
debat
whether
detect
viru
nasopharyng
aspir
truli
prove
activ
respiratori
viral
infect
pavia
especi
virus
like
rhinoviru
adenoviru
enteroviru
frequent
identifi
asymptomat
infant
van
benten
et
al
rhedin
et
al
also
routin
surveil
monitor
respiratori
virus
found
infant
nicu
smit
et
al
thu
remain
unresolv
find
appli
preterm
infant
birth
hospit
sever
studi
jefferson
et
al
bennett
et
al
kujari
et
al
french
et
al
report
strategi
aim
reduc
nosocomi
rvi
nicu
effect
infect
prevent
practic
prove
cohort
infect
patient
staff
protect
equip
gown
glove
hand
hygien
polici
restrict
visitor
period
high
commun
rvi
preval
howev
major
infect
prevent
measur
implement
outbreak
situat
effect
singl
measur
never
explor
systemat
prospect
control
studi
must
howev
acknowledg
design
prospect
studi
investig
prevent
efficaci
one
singl
intervent
clinic
practic
nicu
come
practic
ethic
limit
influenza
viru
infect
long
thought
uncommon
neonat
due
presenc
matern
antibodi
puck
et
al
fact
neonat
gener
reduc
contact
adult
children
infect
influenza
viru
wilkinson
et
al
howev
increas
number
report
influenza
infect
neonat
descript
influenza
spread
within
neonat
unit
importantli
case
sever
influenza
mortal
newborn
especi
preterm
infant
also
report
wilkinson
et
al
sert
et
al
influenza
rna
viru
orthomyxovirida
famili
classifi
type
b
c
influenza
type
respons
clinic
infect
human
wherea
type
b
account
human
infect
type
c
caus
mild
ill
wood
abramson
transmiss
occur
mainli
aerosol
transmiss
larg
droplet
selfinocul
nasal
mucosa
contamin
hand
also
describ
sever
time
tellier
incub
period
influenza
rang
day
viral
shed
occur
day
clinic
symptom
appear
durat
symptomat
period
gelber
ratner
protect
treatment
limit
neonat
especi
preterm
infant
whitley
monto
current
influenza
vaccin
effect
infant
month
age
principi
esposito
import
prevent
method
annual
vaccin
influenza
parent
caregiv
health
care
worker
howev
low
complianc
particularli
health
care
worker
repeatedli
report
kassiano
et
al
also
among
health
care
worker
nicu
milupi
et
al
tsagri
et
al
thu
infect
nicu
staff
may
sourc
nosocomi
outbreak
particularli
earli
onset
phase
infect
pressur
present
work
high
critic
staf
period
despit
obvious
possibl
viciou
circl
low
immun
rate
among
healthcar
likelihood
influenza
pressur
present
work
even
prodrom
symptom
start
identifi
epidemiolog
work
focus
effect
interconnect
era
pcrbase
detect
method
outbreak
influenza
report
nicu
tabl
rocha
et
al
pannaraj
et
al
vij
et
al
milupi
et
al
tsagri
et
al
outbreak
occur
pandem
report
influenza
caus
viru
affect
infant
present
mainli
respiratori
symptom
includ
desatur
tachypnea
increas
secret
apnea
need
mechan
ventil
addit
bradycardia
pyrexia
rale
observ
clinic
featur
may
difficult
distinguish
bacteri
sepsi
one
infant
report
develop
clinic
seizur
infect
influenza
vij
et
al
infant
born
week
postmenstru
age
pma
day
old
onset
influenza
infect
seizur
cerebrospin
fluid
analysi
perform
normal
result
howev
sent
influenza
pcr
also
cranial
mri
reveal
abnorm
patient
fulli
recov
influenza
infect
seizur
describ
associ
influenza
infect
older
children
along
neurolog
manifest
includ
encephalopathi
ekstrand
et
al
kedia
et
al
next
outbreak
descript
case
report
influenza
infect
infant
hospit
nicu
public
israel
report
preterm
infant
week
pma
develop
respiratori
failur
day
life
due
influenza
infant
receiv
neuraminidas
inhibitor
oseltamivir
therapeut
dosag
discharg
good
health
day
life
barak
et
al
contrast
jajoo
et
al
india
publish
case
preterm
infant
week
pma
present
respiratori
failur
day
life
infant
diagnos
influenza
day
life
oseltamivir
start
therapeut
dosag
nevertheless
infant
pneumonia
continu
worsen
infant
die
day
life
due
refractori
shock
multiorgan
dysfunct
jajoo
gupta
best
knowledg
infant
report
die
nicu
due
influenza
infect
wherea
report
infant
recov
fulli
infect
contrast
report
healthcar
set
older
patient
epidem
pandem
influenza
associ
signific
mortal
infant
bhat
et
al
reason
rel
low
mortal
infant
affect
influenza
nicu
unclear
import
fact
might
increas
awar
nicu
staff
especi
time
pandem
consecut
earli
diagnosi
prompt
initi
support
therapi
report
outbreak
also
case
report
influenza
infect
nicu
affect
infant
treat
neuraminidas
inhibitor
oseltamivir
bhat
et
al
jajoo
gupta
rocha
et
al
pannaraj
et
al
milupi
et
al
tsagri
et
al
expos
infant
commonli
receiv
oseltamivir
prophylaxi
rocha
et
al
pannaraj
et
al
milupi
et
al
tsagri
et
al
one
nicu
outbreak
scenario
infant
diagnos
influenza
cohort
isol
without
drug
treatment
also
infant
favor
outcom
vij
et
al
oseltamivir
neuraminidas
inhibitor
effect
influenza
b
convert
activ
metabolit
oseltamivir
carboxyl
hepat
esteras
renal
elimin
glomerular
filtrat
tubular
secret
process
process
diminish
neonat
young
adult
reach
adult
capac
month
age
abdelrahman
et
al
oseltamivir
shown
reduc
durat
ill
previous
healthi
children
h
matheson
et
al
furthermor
significantli
reduc
complic
influenza
particularli
otiti
media
safeti
concern
use
neuraminidas
inhibitor
infant
rais
anim
trial
conduct
us
food
drug
administr
wooltorton
trial
old
rat
fed
excess
high
dose
oseltamivir
time
dose
recommend
children
mani
rat
die
consecut
nevertheless
pandem
us
food
drug
administr
releas
emerg
use
author
eua
oseltamivir
infant
year
age
recommend
dosag
initi
agedepend
correct
weightbas
dose
approach
ie
mgkgdose
oral
twice
daili
children
month
base
casg
collabor
antivir
studi
group
nation
institut
health
nih
usa
studi
result
acosta
et
al
subsequ
conduct
studi
determin
dose
preterm
infant
acosta
et
al
result
studi
suggest
therapeut
oseltamivir
dosag
mgkgdose
twice
daili
well
prophylact
oseltamivir
dosag
mgkgdose
day
prematur
neonat
week
pma
acosta
et
al
treatment
prophylaxi
oseltamivir
must
start
within
h
onset
symptom
exposur
effect
munoz
matheson
et
al
outbreak
report
case
report
oseltamivir
use
therapeut
andor
prophylact
dose
seriou
side
effect
especi
central
nervou
system
toxic
observ
bhat
et
al
jajoo
gupta
rocha
et
al
pannaraj
et
al
vij
et
al
milupi
et
al
tsagri
et
al
mild
gastrointestin
symptom
like
diarrhea
report
laboratori
investig
monitor
hematolog
renal
hepat
function
alter
due
therapi
oseltamivir
thu
oseltamivir
current
recommend
dosag
seem
safe
also
smallest
infant
consid
therapeut
option
outbreak
situat
nicu
human
rhinoviru
hrv
among
frequent
caus
upper
lower
respiratori
tract
infect
infant
hospit
nicu
van
piggelen
et
al
steiner
et
al
hrv
classifi
speci
b
c
within
genu
enteroviru
picornavirida
famili
differ
hrv
genotyp
known
far
hrv
infect
provid
protect
immun
genotyp
low
crossneutr
serotyp
jacob
et
al
might
explan
frequent
occurr
hrv
infect
rhinoviru
speci
c
associ
sever
ill
sever
report
especi
preterm
infant
compar
speci
b
reid
et
al
marcon
et
al
treatment
hrv
infect
limit
symptomat
treatment
five
report
hrv
outbreak
hospit
nicu
patient
identifi
tabl
hrv
speci
c
detect
caus
agent
three
report
reid
et
al
rees
et
al
marcon
et
al
wherea
two
hrv
speci
elucid
due
lack
genotyp
van
piggelen
et
al
steiner
et
al
hrv
affect
term
preterm
infant
mean
age
onset
symptom
day
rang
day
frequent
symptom
nasal
congest
increas
respiratori
secret
increas
work
breath
almost
report
infant
need
increas
respiratori
support
increas
oxygen
supplement
cours
hrv
infect
van
piggelen
et
al
reid
et
al
steiner
et
al
rees
et
al
marcon
et
al
report
van
piggelen
et
al
netherland
van
piggelen
et
al
includ
patient
week
pma
infant
need
mechan
ventil
infecti
episod
gener
sever
respiratori
failur
due
hrv
infect
seem
uncommon
reid
et
al
steiner
et
al
rees
et
al
marcon
et
al
describ
even
otherwis
healthi
term
newborn
broberg
et
al
contrast
patient
requir
mechan
ventil
hrv
infect
report
steiner
et
al
major
comorbid
besid
prematur
giant
thorac
lymphangioma
neuromuscular
impair
owe
sever
perinat
asphyxia
suspect
metabol
disord
respect
steiner
et
al
furthermor
steiner
et
al
report
presenc
apnea
hrv
infect
correl
sever
diseas
cours
steiner
et
al
infant
report
literatur
recov
hrv
infect
one
studi
van
piggelen
et
al
report
infant
develop
recurr
respiratori
tract
infect
first
year
life
accord
author
could
explain
sole
prematur
data
avail
possibl
longterm
consequ
hrv
infect
earli
period
life
also
limit
data
exist
nosocomi
hrv
transmiss
reid
et
al
rees
et
al
marcon
et
al
known
hrv
remain
viabl
hour
day
environment
surfac
ambient
temperatur
thu
transmiss
occur
via
direct
contact
aerosol
jacob
et
al
challeng
hrv
viru
shed
report
occur
day
otherwis
healthi
preterm
infant
steiner
et
al
marcon
et
al
manag
infant
posit
pcr
result
resolv
clinic
sign
nicu
problemat
date
studi
correl
viral
load
either
infecti
presenc
infecti
viral
particl
rsv
envelop
nonseg
negativesens
rna
viru
belong
pneumovirida
famili
classifi
genu
orthopneumoviru
divid
two
antigen
subgroup
b
rsv
lead
caus
hospit
respiratori
ill
children
month
age
iwan
et
al
caus
season
outbreak
worldwid
symptom
rsv
infect
rang
afebril
cough
congest
sever
bronchiol
pneumonia
respiratori
failur
risk
sever
rsv
infect
infant
age
month
preterm
infant
born
prior
week
pma
infant
children
underli
lung
diseas
congenit
heart
diseas
boyc
et
al
studi
report
sever
diseas
cours
rsv
subtyp
infect
compar
subytp
b
halasa
et
al
buonocor
et
al
rsv
spread
close
contact
via
direct
inocul
largeparticl
aerosol
selfinocul
touch
contamin
surfac
rsv
also
abl
spread
hemtogen
primari
site
infect
remot
extrapulmonari
tissu
eisenhut
viru
replic
nasal
ocular
mucos
epithelium
goldmann
although
rsv
rel
labil
viru
surviv
h
surfac
provid
opportun
environment
nosocomi
transmiss
homaira
et
al
examin
cloth
health
care
worker
visitor
potenti
sourc
rsv
infect
nicu
detect
rsvrna
low
viral
load
cloth
health
care
worker
homaira
et
al
older
studi
found
freshli
obtain
secret
infect
infant
surviv
cloth
health
care
worker
min
hall
et
al
thu
carriag
cloth
may
contribut
nosocomi
infect
nicu
rsv
detect
rate
nicu
absenc
outbreak
seem
low
studi
indic
rate
winter
epidem
berger
et
al
homaira
et
al
howev
nosocomi
rsv
infect
report
caus
sever
cours
commun
acquir
rsv
infect
simon
et
al
lead
high
morbid
signific
mortal
substanti
increas
health
care
cost
halasa
et
al
limit
number
report
literatur
nosocomi
acquir
rsv
infect
among
term
preterm
infant
nicu
bont
four
nicu
outbreak
rsv
report
use
rtpcr
technolog
viru
detect
halasa
et
al
visser
et
al
oconnel
et
al
hammoud
et
al
tabl
report
infant
present
sign
respiratori
deterior
need
increas
respiratori
support
gener
rsv
infect
nicu
occur
mostli
late
clinic
cours
ie
mean
age
one
month
tabl
howev
individu
infect
earli
day
life
report
tabl
mani
infant
need
mechan
ventil
cours
rsv
infect
one
case
report
requir
extracorpor
membran
oxygen
ecmo
halasa
et
al
still
infant
recov
rsv
infect
studi
berger
et
al
patient
parent
staff
screen
rsv
nicu
period
week
sampl
test
posit
rsv
infant
howev
diagnos
rsv
infect
studi
fatal
outcom
infant
preterm
week
pma
infant
first
symptom
rsv
infect
day
life
unev
clinic
cours
emphas
risk
advers
outcom
nosocomi
rsv
infect
especi
prematur
infant
also
studi
visser
et
al
report
outbreak
rsv
south
african
kangaroo
mother
care
unit
infant
die
due
fatal
cours
rsv
infect
patient
male
born
week
pma
respect
first
child
suffer
dual
infect
rsv
b
second
infect
rsv
b
visser
et
al
high
mortal
morbid
report
special
patient
group
prophylact
immun
palivizumab
recommend
monthli
rsv
season
simo
american
academi
pediatr
bronchiol
guidelin
committe
palivizumab
monoclon
antibodi
usual
administ
prior
hospit
discharg
protect
communityacquir
rsv
infect
american
academi
pediatr
bronchiol
guidelin
committe
administ
correctli
palivizumab
shown
safe
effect
reduc
number
rsvrelat
hospit
random
multicent
placebocontrol
trial
wegzyn
et
al
also
report
outbreak
scenario
author
chose
administ
palivizumab
either
infant
hospit
nicu
oconnel
et
al
hammoud
et
al
subgroup
nicu
patient
consid
particularli
increas
risk
nosocomi
rsv
infect
halasa
et
al
report
success
termin
outbreak
despit
anecdot
report
immunoprophylaxi
palivizumab
current
recommend
prevent
health
careassoci
rsv
infect
american
academi
pediatr
bronchiol
guidelin
committe
sever
author
highlight
infect
control
method
adequ
hand
washinghand
disinfect
rapid
screen
infect
cohort
infect
patient
effect
prevent
rsv
transmiss
nicu
pediatr
ward
groothui
et
al
rvi
still
underdiagnos
underestim
entiti
nicu
although
incid
rvi
rel
low
outbreak
rare
rvi
caus
signific
morbid
neonat
especi
preterm
infant
thu
pcr
base
viru
detect
method
consid
infant
hospit
nicu
sign
respiratori
deterior
order
allow
rapid
diagnosi
rvi
implement
rapidli
effect
isol
infect
prevent
measur
prevent
sever
diseas
these
infant
viral
spread
unit
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
